NewslettersDermal Cell News FDA Approves Incyte Drug for Rare Skin Cancer Merkel Cell Carcinoma By lbeveridge - March 27, 2023 0 Regulatory approval of Incyte’s cancer immunotherapy, Zynyz, comes two years after the FDA rejected an application seeking approval in a rare type of anal cancer. [MedCityNews] Press Release